| Subject: Transfer Factor used for Cancer Patients |
Author:
Ross
|
[
Next Thread |
Previous Thread |
Next Message |
Previous Message
]
Date Posted: 11:44:03 12/11/04 Sat
Transfer Factor is a food supplement !
==============================
Transfer Factor and Cancer
Dr. See Abstracts
------------------------------------------------------------------
The study that Dr Darryl See carried out on the 20 cancer patients that we have talked about and listened to from the conference calls has been published . 16 out of the 20 late stage (stage IV) cancer patients were alive and in remission after the 6 month study (see below for the abstract of the publication).
We have subsequently heard from Dr Darryl that at 8 months and later an update from Dr Foo that at 12 months the 16 patients were still alive and in remission or getting better.
Dr Darryl See was very excited to use Transfer Factor Plus which he found to have "unprecedented" and very exciting immune boosting and modulating properties. The Transfer Factor plus had raised the NK cell to the extent that it was 500 % higher than the next highest product. In his conference call he said he chose to give Transfer Factor the "most severe test", and chose end stage cancer patients to further study Tranfer Factor plus. In the study he used some additional nutritional supplement to support the patients.
**********
Immunol Invest 2002 May;31(2):137-53
Increased tumor necrosis factor alpha (TNF-alpha) and natural killer cell (NK) function using an integrative approach in late stage cancers.
See D, Mason S, Roshan R.
Center for Advanced Medicine, Encinitias, California 92024, USA.
Natural products may increase cytotoxic activity of Natural Killer Cells (NK) Tumor Necrosis Factor alpha (TNF-alpha) while decreasing DNA damage in patients with late-stage cancer. Pilot studies have suggested that a combination of Nutraceuticals can raise NK cell function and TNF-alpha alpha activity and result in improved clinical outcomes in patients with late stage cancer. The objective of the study is to determine if Nutraceuticals can significantly raise NK function and TNF levels in patients with late stage cancer. After informed consent was obtained, 20 patients with stage IV, end-stage cancer were evaluated (one bladder, five breast, two prostate, one neuroblastoma, two non-small cell lung, three colon, 1 mesothelioma, two lymphoma, one ovarian, one gastric, one osteosarcoma). Transfer Factor Plus (TFP+, 3 tablets 3 times per day), IMUPlus (non denatured milk whey protein, 40 gm/day); Intravenous (50 to 100 gm/day) and oral (1-2 gm/day) ascorbic acid; Agaricus Blazeii Murill teas (10 gm/day); Immune Modulator Mix (a combination of vitamin, minerals, antioxidants and immune-enhancing natural products); nitrogenated soy extract (high levels of genistein and dadzein) and Andrographis Paniculata (500 mg twice, daily) were used. Baseline NK function by standard 4 h 51Cr release assay and TNF alpha and receptor levels were measured by ELISA from resting and phytohemagglutinin (PHA) stimulated adherent and non-adherent Peripheral Blood Mononuclear Cell (PBMC). Total mercaptans and glutathione in plasma were taken and compared to levels measured 6 months later. Complete blood counts and chemistry panels were routinely monitored. As of a mean of 6 months, 16/20 patients were still alive. The 16 survivors had significantly higher NK function than baseline (p < .01 for each) and TNF-alpha levels in all four cell populations studied (p < .01 for each). Total mercaptans (p < .01) and TNF-alpha receptor levels were significantly reduced (p < .01). It was also observed that hemoglobin, hematocrit and glutathione levels were significantly elevated. The only toxicity noted was occasional diarrhea and nausea. The quality of life improved for all survivors by SF-36 form evaluation. An aggressive combination of immunoactive Nutraceuticals was effective in significantly increasing NK function, other immune parameters and hemoglobin from PBMC or plasma in patients with late stage cancers. Nutraceutical combinations may be effective in late stage cancers. Clinical outcomes evaluations are ongoing.
INCREASED TUMOR NECROSIS FACTOR ALPHA AND NK CELL FUNCTION
USING AN INTEGRATIVE APPROACH IN LATE STAGE CANCERS
PATIENT DEMOGRAPHICS PATIENT REGIME INCLUDED RESULTS AFTER SIX MONTHS
Twenty patients
Average age: 49.3
All stage 4 cancers
12 males, 8 females
Prognosis from physician: 3.7 months to live Transfer Factor Plus, Beta Glucans, soy
extract, digestive enzymes, vegetarian,
low-sugar diet, hyperthermia and more. Average Tumor Necrosis Factor alpha
(TNF) increased from 12.4 to 1287.5
Average increase in NK cell function:
6.4 to 27.6
=====================
Listen to the short presentation here....
http://www.globalsuccess4life.com/movie/flash2_3.swf
and you decide!
Read and understand the greatest findings of the century !
- www.transferfactorinstitute.com
- www.transferfactorresearch.com
- http://www.professionalnetworkers.com
http://www.geocities.com/forlife4malaysia/
- www.4life.com.my
- www.4life.com
- My UPLINE website: http://sheridin.my4life.com/
M.Rosman
Malaysia
Email: mrosman@streamyx.com
HP: +60 19 913 7172
[
Next Thread |
Previous Thread |
Next Message |
Previous Message
]
| |
Feedback: 